AR056014A1 - Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo - Google Patents
Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismoInfo
- Publication number
- AR056014A1 AR056014A1 ARP060103362A ARP060103362A AR056014A1 AR 056014 A1 AR056014 A1 AR 056014A1 AR P060103362 A ARP060103362 A AR P060103362A AR P060103362 A ARP060103362 A AR P060103362A AR 056014 A1 AR056014 A1 AR 056014A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- preparation
- pharmaceutical composition
- composition containing
- aminocarbazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Composicion farmacéutica que contiene un compuesto de formula (1) o una sal farmacéuticamente aceptable del mismo. Procedimiento para la preparacion del compuesto mencionado anteriormente de formula (1) y las sales farmacéuticamente aceptables del mismo. Reivindicacion 1: Compuesto 3-aminocarbazol, caracterizado porque se selecciona de entre el grupo que comprende los compuestos de la Tabla 1 siguiente, y una sal farmacéuticamente aceptable de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001523A ITMI20051523A1 (it) | 2005-08-03 | 2005-08-03 | Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo |
Publications (1)
Publication Number | Publication Date |
---|---|
AR056014A1 true AR056014A1 (es) | 2007-09-12 |
Family
ID=35501077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060103362A AR056014A1 (es) | 2005-08-03 | 2006-08-02 | Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo |
Country Status (24)
Country | Link |
---|---|
US (2) | US7879900B2 (es) |
EP (1) | EP1910288B1 (es) |
JP (1) | JP5274252B2 (es) |
KR (1) | KR101278620B1 (es) |
CN (1) | CN101223139B (es) |
AR (1) | AR056014A1 (es) |
AT (1) | ATE471930T1 (es) |
AU (1) | AU2006275063B2 (es) |
BR (1) | BRPI0615158A8 (es) |
CA (1) | CA2609441C (es) |
DE (1) | DE602006015062D1 (es) |
DK (1) | DK1910288T3 (es) |
EA (1) | EA012786B1 (es) |
ES (1) | ES2345944T3 (es) |
GE (1) | GEP20104964B (es) |
HK (1) | HK1112916A1 (es) |
IL (1) | IL187713A (es) |
IT (1) | ITMI20051523A1 (es) |
MX (1) | MX2008001551A (es) |
PL (1) | PL1910288T3 (es) |
PT (1) | PT1910288E (es) |
SI (1) | SI1910288T1 (es) |
UA (1) | UA93378C2 (es) |
WO (1) | WO2007014687A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2119705A1 (en) * | 2008-05-14 | 2009-11-18 | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. | 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor |
GB0812185D0 (en) | 2008-07-03 | 2008-08-13 | Dow Corning | Polymers modified by silanes |
GB0812186D0 (en) | 2008-07-03 | 2008-08-13 | Dow Corning | Modified polyolefins |
WO2010019271A1 (en) * | 2008-08-15 | 2010-02-18 | Georgetown University | Fluorescent regulators of rassf1a expression and human cancer cell proliferation |
GB201000121D0 (en) | 2010-01-06 | 2010-02-17 | Dow Corning | Modified polyolefins |
GB201000117D0 (en) | 2010-01-06 | 2010-02-17 | Dow Corning | Organopolysiloxanes containing an unsaturated group |
GB201000120D0 (en) | 2010-01-06 | 2010-02-17 | Dow Corning | Process for forming crosslinked and branched polymers |
GB201000128D0 (en) | 2010-01-06 | 2010-02-24 | Dow Corning | Modified polymers |
GB201006846D0 (en) | 2010-04-23 | 2010-06-09 | Glaxo Group Ltd | Novel compounds |
MX2010014124A (es) * | 2010-12-17 | 2012-06-18 | Gabriel Diaz Hernandez | Solución antiséptica local de amplio espectro a base de hipodorito de sodio, bicarbonato de sodio, cloramfenicol, jabón y solución salina al 0.9%. |
FR2972193B1 (fr) | 2011-03-04 | 2014-07-04 | Setup Performance | Polyolefines modifiees, reticulables apres transformation, et procede de fabrication desdites polyolefines |
US10376672B2 (en) | 2013-03-15 | 2019-08-13 | Auris Health, Inc. | Catheter insertion system and method of fabrication |
US11053255B2 (en) | 2015-06-22 | 2021-07-06 | Georgetown University | Synthesis of mahanine and related compounds |
CN115335046A (zh) * | 2020-03-25 | 2022-11-11 | 思研(Sri)国际顾问与咨询公司 | 脂肪氧合酶抑制剂 |
CN112159345B (zh) * | 2020-11-18 | 2023-08-25 | 湖北和昌新材料科技股份有限公司 | N-乙基咔唑的合成方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940719A (en) * | 1986-03-27 | 1990-07-10 | Merck Frosst Canada, Inc. | Tetrahydrocarbazole esters, pharmaceutical compositions and use |
JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
AU6000900A (en) | 1999-07-23 | 2001-02-13 | Astrazeneca Uk Limited | Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
US6399631B1 (en) | 1999-07-23 | 2002-06-04 | Pfizer Inc. | Carbazole neuropeptide Y5 antagonists |
WO2001013917A1 (en) * | 1999-08-26 | 2001-03-01 | Bristol-Myers Squibb Company | Npy antagonists: spiroisoquinolinone derivatives |
CA2432008A1 (en) | 2000-12-22 | 2002-07-04 | Astrazeneca Ab | Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
DE10125961A1 (de) * | 2001-05-29 | 2002-12-12 | Boehringer Ingelheim Int | Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden |
CA2403307A1 (en) * | 2001-10-23 | 2003-04-23 | Neurogen Corporation | Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives |
ES2193875B2 (es) * | 2002-04-09 | 2005-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos. |
ITMI20050909A1 (it) | 2005-05-19 | 2006-11-20 | Acraf | Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2- |
-
2005
- 2005-08-03 IT IT001523A patent/ITMI20051523A1/it unknown
-
2006
- 2006-07-25 UA UAA200801219A patent/UA93378C2/ru unknown
- 2006-07-25 JP JP2008524404A patent/JP5274252B2/ja not_active Expired - Fee Related
- 2006-07-25 GE GEAP200610547A patent/GEP20104964B/en unknown
- 2006-07-25 EA EA200800502A patent/EA012786B1/ru not_active IP Right Cessation
- 2006-07-25 EP EP06776431A patent/EP1910288B1/en active Active
- 2006-07-25 CN CN2006800258375A patent/CN101223139B/zh not_active Expired - Fee Related
- 2006-07-25 AU AU2006275063A patent/AU2006275063B2/en not_active Ceased
- 2006-07-25 CA CA2609441A patent/CA2609441C/en not_active Expired - Fee Related
- 2006-07-25 SI SI200630776T patent/SI1910288T1/sl unknown
- 2006-07-25 DE DE602006015062T patent/DE602006015062D1/de active Active
- 2006-07-25 DK DK06776431.6T patent/DK1910288T3/da active
- 2006-07-25 AT AT06776431T patent/ATE471930T1/de active
- 2006-07-25 PT PT06776431T patent/PT1910288E/pt unknown
- 2006-07-25 US US11/916,487 patent/US7879900B2/en not_active Expired - Fee Related
- 2006-07-25 ES ES06776431T patent/ES2345944T3/es active Active
- 2006-07-25 BR BRPI0615158A patent/BRPI0615158A8/pt not_active IP Right Cessation
- 2006-07-25 WO PCT/EP2006/007393 patent/WO2007014687A1/en active Application Filing
- 2006-07-25 PL PL06776431T patent/PL1910288T3/pl unknown
- 2006-07-25 MX MX2008001551A patent/MX2008001551A/es active IP Right Grant
- 2006-07-25 KR KR1020087002766A patent/KR101278620B1/ko not_active IP Right Cessation
- 2006-08-02 AR ARP060103362A patent/AR056014A1/es not_active Application Discontinuation
-
2007
- 2007-11-28 IL IL187713A patent/IL187713A/en not_active IP Right Cessation
-
2008
- 2008-07-23 HK HK08108149.5A patent/HK1112916A1/xx not_active IP Right Cessation
-
2010
- 2010-10-28 US US12/914,551 patent/US8207214B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR056014A1 (es) | Compuesto 3-aminocarbazol, composicion farmaceutica que lo contiene y procedimiento para la preparacion del mismo | |
AR056873A1 (es) | Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas | |
AR058901A1 (es) | Compuestos derivados de hidantoina, utiles para el tratamiento de trastornos inflamatorios y composicion farmaceutica que los comprende | |
AR106237A2 (es) | Inhibidores heterocíclicos de la aspartil proteasa, sus sales farmacéuticamente aceptables | |
AR058780A1 (es) | Imidazopirazinas como inhibidores de quinasas dependientes de ciclina | |
AR063096A1 (es) | Pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina | |
AR051405A1 (es) | Compuestos de 2-carboxamido(3-amino)tiofeno | |
AR063097A1 (es) | Pirazolopirimidinas[1,5-a] inhibidoras de quinasas dependientes de ciclina(cdk), composiciones farmaceuticas que las contienen y usos en el tratamiento de enfermedades proliferativas | |
GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
AR088808A2 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
CR20140368A (es) | Derivados y composiciones de isoindol 4´-0-sustituidos, composiciones que las comprenden y metodos de uso de los mismos (divisional 11036) | |
AR058293A1 (es) | Sales profarmacos y formulaciones de 1-[5-(4-amino-7-isopropil-7h-pirrolo[2,3-d]pirimidin-5-carbonil)-2-metoxi-fenil]-3-(2,4-dicloro-fenil)-urea | |
GT200600518A (es) | Derivados de pirimidina | |
EA201001013A1 (ru) | Бис(сульфониламино)производные для применения в терапии | |
ECSP056194A (es) | Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa | |
UY29087A1 (es) | Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico | |
UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
DOP2006000243A (es) | Derivados de pirazina | |
AR049681A1 (es) | Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas | |
AR056574A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
UY28979A1 (es) | Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3 | |
ECSP10010303A (es) | (dihidro)pirrolo[2,1-a]isoquinolinas | |
AR056860A1 (es) | Derivados de triazol inhibidores de receptores de quinasa tgf-beta1, composiciones farmaceuticas que los contienen y usos para el tratamiento de tumores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed, e.g., due to non-payment of fee |